228 related articles for article (PubMed ID: 20661889)
1. Carrier detection and prenatal diagnosis of congenital adrenal hyperplasia must identify 'apparently mild' CYP21A2 alleles which associate neonatal salt-wasting disease.
Ezquieta B; Santomé L; Barrio R; Barrionuevo JL; López-Siguero JP; Oliver A; Ramírez J; Rodríguez I; Muñoz-Pacheco R
Prenat Diagn; 2010 Aug; 30(8):758-63. PubMed ID: 20661889
[TBL] [Abstract][Full Text] [Related]
2. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
3. Gene duplications in 21-hydroxylase deficiency: the importance of accurate molecular diagnosis in carrier detection and prenatal diagnosis.
Ezquieta B; Beneyto M; Muñoz-Pacheco R; Barrio R; Oyarzabal M; Lechuga JL; Luzuriaga C; Hermoso F; Quinteiro S; Martinez S
Prenat Diagn; 2006 Dec; 26(12):1172-8. PubMed ID: 17042033
[TBL] [Abstract][Full Text] [Related]
4. CYP21A2 Gene Pathogenic Variants: A Multicenter Study on Genotype-Phenotype Correlation from a Portuguese Pediatric Cohort.
Santos-Silva R; Cardoso R; Lopes L; Fonseca M; Espada F; Sampaio L; Brandão C; Antunes A; Bragança G; Coelho R; Bernardo T; Vieira P; Morais R; Leite AL; Ribeiro L; Carvalho B; Grangeia A; Oliveira R; Oliveira MJ; Rey V; Rosmaninho-Salgado J; Marques B; Garcia AM; Meireles A; Carvalho J; Sequeira A; Mirante A; Borges T;
Horm Res Paediatr; 2019; 91(1):33-45. PubMed ID: 30889569
[TBL] [Abstract][Full Text] [Related]
5. Genetic and clinical characteristics including occurrence of testicular adrenal rest tumors in Slovak and Slovenian patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Saho R; Dolzan V; Zerjav Tansek M; Pastorakova A; Petrovic R; Knapkova M; Trebusak Podkrajsek K; Suput Omladic J; Bertok S; Avbelj Stefanija M; Kotnik P; Battelino T; Pribilincova Z; Groselj U
Front Endocrinol (Lausanne); 2023; 14():1134133. PubMed ID: 37008950
[TBL] [Abstract][Full Text] [Related]
6. A new CYP21A2 nonsense mutation causing severe 21-hydroxylase deficiency.
Concolino P; Minucci A; Mello E; Zuppi C; Capoluongo E
Clin Chem Lab Med; 2009; 47(7):824-5. PubMed ID: 19499972
[TBL] [Abstract][Full Text] [Related]
7. Erroneous prenatal diagnosis of congenital adrenal hyperplasia owing to a duplication of the CYP21A2 gene.
Lekarev O; Tafuri K; Lane AH; Zhu G; Nakamoto JM; Buller-Burckle AM; Wilson TA; New MI
J Perinatol; 2013 Jan; 33(1):76-8. PubMed ID: 23269230
[TBL] [Abstract][Full Text] [Related]
8. Steroid 21-hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype-phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia.
Marino R; Ramirez P; Galeano J; Perez Garrido N; Rocco C; Ciaccio M; Warman DM; Guercio G; Chaler E; Maceiras M; Bergadá I; Gryngarten M; Balbi V; Pardes E; Rivarola MA; Belgorosky A
Clin Endocrinol (Oxf); 2011 Oct; 75(4):427-35. PubMed ID: 21609351
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Forest MG
Hum Reprod Update; 2004; 10(6):469-85. PubMed ID: 15514016
[TBL] [Abstract][Full Text] [Related]
10. Rare mutations in the CYP21A2 gene detected in congenital adrenal hyperplasia.
Neocleous V; Ioannou YS; Bartsota M; Costi C; Skordis N; Phylactou LA
Clin Biochem; 2009 Sep; 42(13-14):1363-7. PubMed ID: 19501079
[TBL] [Abstract][Full Text] [Related]
11. Genetic Characterization of a Cohort of Italian Patients with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.
Concolino P; Perrucci A; Carrozza C; Urbani A
Mol Diagn Ther; 2023 Sep; 27(5):621-630. PubMed ID: 37548905
[TBL] [Abstract][Full Text] [Related]
12. High carrier frequency of 21-hydroxylase deficiency in Cyprus.
Phedonos AA; Shammas C; Skordis N; Kyriakides TC; Neocleous V; Phylactou LA
Clin Genet; 2013 Dec; 84(6):585-8. PubMed ID: 23600966
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of patient and carrier genes with congenital steroid 21-hydroxylase deficiency by using polymerase chain reaction and single strand conformation polymorphism.
Tajima T; Fujieda K; Nakayama K; Fujii-Kuriyama Y
J Clin Invest; 1993 Nov; 92(5):2182-90. PubMed ID: 8227333
[TBL] [Abstract][Full Text] [Related]
14. Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction.
de Carvalho DF; Miranda MC; Gomes LG; Madureira G; Marcondes JA; Billerbeck AE; Rodrigues AS; Presti PF; Kuperman H; Damiani D; Mendonca BB; Bachega TA
Eur J Endocrinol; 2016 Aug; 175(2):107-16. PubMed ID: 27185867
[TBL] [Abstract][Full Text] [Related]
15. Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment.
Carlson AD; Obeid JS; Kanellopoulou N; Wilson RC; New MI
J Steroid Biochem Mol Biol; 1999; 69(1-6):19-29. PubMed ID: 10418977
[TBL] [Abstract][Full Text] [Related]
16. Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran.
Baradaran-Heravi A; Vakili R; Robins T; Carlsson J; Ghaemi N; A'rabi A; Abbaszadegan MR
Clin Endocrinol (Oxf); 2007 Sep; 67(3):335-41. PubMed ID: 17573904
[TBL] [Abstract][Full Text] [Related]
17. The Spectrum of Genetic Defects in Congenital Adrenal Hyperplasia in the Population of Cyprus: A Retrospective Analysis.
Neocleous V; Fanis P; Toumba M; Stylianou C; Picolos M; Andreou E; Kyriakou A; Iasonides M; Nicolaou S; Kyriakides TC; Tanteles GA; Skordis N; Phylactou LA
Horm Metab Res; 2019 Sep; 51(9):586-594. PubMed ID: 31505704
[TBL] [Abstract][Full Text] [Related]
18. CYP21A2 p.E238 deletion as result of multiple microconversion events: a genetic study on an Italian congenital adrenal hyperplasia (CAH) family.
Concolino P; Mello E; Zuppi C; Toscano V; Capoluongo E
Diagn Mol Pathol; 2013 Mar; 22(1):48-51. PubMed ID: 23370425
[TBL] [Abstract][Full Text] [Related]
19. Development of CYP21A2 Genotyping Assay for the Diagnosis of Congenital Adrenal Hyperplasia.
Prado MJ; de Castro SM; Kopacek C; de Mello MP; Rispoli T; Grandi T; da Silva CMD; Rossetti MLR
Mol Diagn Ther; 2017 Dec; 21(6):663-675. PubMed ID: 28819757
[TBL] [Abstract][Full Text] [Related]
20. p.H282N and p.Y191H: 2 novel CYP21A2 mutations in Italian congenital adrenal hyperplasia patients.
Concolino P; Mello E; Patrosso MC; Penco S; Zuppi C; Capoluongo E
Metabolism; 2012 Apr; 61(4):519-24. PubMed ID: 22014889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
